"Europe is facing a healthcare crunch as a result of our ageing population. By making the most use of digital tech, we can reduce costs, put the patient back in control, make healthcare more efficient and help European citizens to take an active part in society for longer. We have to keep our finger on the pulse!" - Neelie Kroes.
Read more ...
The Human Brain Project Just Got Bigger
One of the biggest EU-funded initiatives, the Human Brain Project (HBP), today announced the beneficiaries of its €8.3 million competitive call for new partners. 32 organisations from 13 countries - Austria, Belgium, Cyprus, Finland, France, Germany, Israel, Italy, Netherlands, Slovenia, Spain, Switzerland and the UK - will join the partnership. This represents a 40% increase in the number of partners in the HBP consortium.
Read more ...
New IMI Project to Incorporate Real Life Data into Drug Development
The Innovative Medicines Initiative (IMI) has launched a new project called GETREAL that will investigate new ways of integrating data from real life settings, such as clinics, into drug development. This will assist healthcare decision makers when deciding how best to grant patients access to a new treatment and help pharmaceutical companies to take better decisions during drug development.
Read more ...
Antilope Calls for Development of eHealth Testing Tools
Today the EU-funded Antilope project published a request for proposals (RFP) for developing testing tools that further enhance testing for the profiles and standards needed to implement the use cases identified in the European eHealth Interoperability Framework (eEIF). These new testing tools will serve to further advance eHealth interoperability in Europe. The Antilope project has published a list of testing tools that are used to ensure interoperability with existing IT infrastructures, services and devices.
Read more ...
Phantom Limb Pain Relieved with Augmented Reality
Researcher at Chalmers University of Technology, University of Gothenburg and Sahlgrenska University Hospital has developed a new method for the treatment of phantom limb pain (PLP) after an amputation. The method is based on a unique combination of several technologies, and has been initially tested on a patient who has suffered from severe phantom limb pain for 48 years. A case study shows a drastic reduction of pain.
Read more ...
3 Research Projects that Led to High-Tech Spin-Offs
Today the European Women Innovator Award was awarded to Ana Maiques @ana_maiques. Ms Maiques said: "To be a top innovator, you have to be able to do cutting edge science - but also take it to market." This is exactly what she has done with her spin-off company Neuroelectrics @Neuroelectrics which develops revolutionary brain devices.
Read more ...
Detecting Software Errors via Genetic Algorithms
According to a current study from the University of Cambridge, software developers are spending about the half of their time on detecting errors and resolving them. Projected onto the global software industry, according to the study, this would amount to a bill of about 312 billion US dollars every year. "Of course, automated testing is cheaper", explains Andreas Zeller, professor of Software Engineering at Saarland University, as you could run a program a thousand times without incurring any charges. "But where do these necessary test cases come from?" asks Zeller. "Generating them automatically is tough, but thinking of them yourself is even tougher."
Read more ...
"Europe is facing a healthcare crunch as a result of our ageing population. By making the most use of digital tech, we can reduce costs, put the patient back in control, make healthcare more efficient and help European citizens to take an active part in society for longer. We have to keep our finger on the pulse!" - Neelie Kroes. 
The Innovative Medicines Initiative (IMI) has launched a new project called GETREAL that will investigate new ways of integrating data from real life settings, such as clinics, into drug development. This will assist healthcare decision makers when deciding how best to grant patients access to a new treatment and help pharmaceutical companies to take better decisions during drug development.